2m 2m 2m 2m 2m 2m 2m
Theraptc Soltns (TSOI)
OTC
$0.000001$0.00 (0.00%)
Price as of Jun 03, 2026- $5,122.00Market Cap
- -99.00%1-Year Change
- BiotechnologyIndustry
Theraptc Soltns (TSOI)
$0.000001$0.00 (0.00%)
Annual
Quarterly
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 98,994 -52.12% | 206,767 +41.66% | 145,956 +132.86% | 62,681 N/A | |
Cost of Revenue | 36,768 -53.72% | 79,440 +86.72% | 42,544 N/A | N/A N/A | |
Gross Profit | 62,226 -51.13% | 127,327 +23.13% | 103,412 +107.28% | 49,889 N/A | |
Sales and Marketing Expense | 3,549 -14.11% | 4,132 N/A | N/A N/A | N/A N/A | |
Research and Development Expense | -560,654 -61.10% | -1.4M +81.33% | -794,750 +41.42% | -561,990 N/A | |
Depreciation and Amortization Expense | 300,897 +28.76% | 233,685 +1,968.92% | 11,295 +71.37% | 6,591 N/A | |
Total Operating Expenses | 2.0M -36.12% | 3.2M +33.21% | 2.4M +26.76% | 1.9M N/A | |
Operating Profit | -2.0M -35.50% | -3.1M +33.66% | -2.3M +24.59% | -1.8M N/A | |
Interest Income | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Expense | -423,265 -34.49% | -646,089 +5.61% | -611,794 +102.26% | -302,481 N/A | |
Interest Income and Expense and Net | -423,265 -34.49% | -646,089 +5.61% | -611,794 +102.26% | -302,481 N/A | |
Total Nonoperating Income and Expense | -235,971 -60.48% | -597,083 -9.02% | -656,299 +87.34% | -350,321 N/A | |
Income before Taxes | -2.2M -39.56% | -3.7M +24.20% | -3.0M +60.07% | -1.8M N/A | |
Income Taxes | 2,250 +181.25% | 800 0.00% | 800 N/A | N/A N/A | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | 206,501 N/A | |
Net Income | -2.2M -41.00% | -3.7M -125.90% | 14.2M +745.48% | -2.2M N/A | |
Net Income from Continuing Operations Applicable to Common | -2.2M -39.56% | -3.7M +24.20% | -3.0M +34.58% | -2.2M N/A | |
Basic EPS and Net Income | 0.00 N/A | 0.00 N/A | 0.00 N/A | 0.00 N/A | |
Diluted EPS and Net Income | 0.00 N/A | 0.00 N/A | 0.00 N/A | 0.00 N/A | |
Basic Weighted Average Shares | 3.2B +25.35% | 2.5B +11.71% | 2.3B +18.37% | 1.9B N/A | |
Diluted Weighted Average Shares | 3.2B +25.35% | 2.5B +11.71% | 2.3B +18.37% | 1.9B N/A | |
Balance Sheet | |||||
Cash and Cash Equivalents | 27,823 +54.23% | 18,040 -80.82% | 94,036 -62.71% | 252,147 N/A | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 27,823 +54.23% | 18,040 -80.82% | 94,036 -62.71% | 252,147 N/A | |
Total Current Assets | 85,913 -72.22% | 309,221 -72.39% | 1.1M +222.29% | 347,517 N/A | |
Accumulated Depreciation | 39,162 +38.47% | 28,281 +65.05% | 17,135 +4.80% | 16,350 N/A | |
Property and Plant and Equipment and Net | 374,355 +37.09% | 273,078 -3.85% | 284,024 +5,514.23% | 5,059 N/A | |
Total Long-Term Assets | 2.7M -10.23% | 3.0M +986.07% | 277,571 +44.63% | 191,922 N/A | |
Total Assets | 3.3M -8.70% | 3.6M +110.14% | 1.7M +184.32% | 603,474 N/A | |
Income Taxes Payable | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Short-Term Debt | 1.5M +37.91% | 1.1M +1.35% | 1.0M +6.42% | 981,436 N/A | |
Total Current Liabilities | 1.9M -14.06% | 2.2M -11.46% | 2.5M +6.35% | 2.3M N/A | |
Total Long-Term Debt | 5,512 -47.54% | 10,507 -32.35% | 15,532 N/A | N/A N/A | |
Total Long-Term Liabilities | 110,544 +952.10% | 10,507 -56.84% | 24,342 -28.79% | 34,184 N/A | |
Total Liabilities | 2.0M -9.48% | 2.2M -11.90% | 2.5M +5.84% | 2.4M N/A | |
Retained Earnings | -20.3M +15.02% | -17.7M +26.28% | -14.0M +26.84% | -11.0M N/A | |
Total Stockholders Equity | 1.1M -18.74% | 1.4M +272.03% | -804,982 -54.73% | -1.8M N/A | |
Total Shares Outstanding | 3.8B +45.28% | 2.6B +13.25% | 2.3B +3.46% | 2.2B N/A | |
Cash Flow | |||||
Cash from Operating Activities | -1.1M +3.63% | -1.0M +41.64% | -718,922 +8.42% | -663,079 N/A | |
Capital Expenditures | 16,158 N/A | N/A N/A | 260,565 +4,682.76% | 5,448 N/A | |
Cash from Investing Activities | -24,000 N/A | N/A N/A | -256,550 +4,609.07% | -5,448 N/A | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 1.1M +14.27% | 943,088 +15.38% | 817,382 -8.60% | 894,279 N/A | |
Financials Ratio | |||||
Gross Margin | 62.86% +2.08% | 61.58% -13.09% | 70.85% N/A | N/A N/A | |
Operating Margin | -2,006.67% +34.71% | -1,489.57% -5.65% | -1,578.79% -46.50% | -2,950.78% N/A | |
Return on Assets | -62.92% -54.48% | -138.23% -111.29% | 1,224.53% +354.51% | -481.13% N/A | |
Return on Equity | -172.89% -86.37% | -1,268.64% +15.39% | -1,099.46% -1,052.86% | 115.39% N/A | |
Revenue Growth | -52.12% -225.10% | 41.66% -68.64% | 132.86% +3.82% | 127.97% N/A | |
Current Ratio | 0.05 -67.69% | 0.14 -68.81% | 0.45 +203.11% | 0.15 N/A | |
Cash Ratio | 0.01 +78.05% | 0.008 -78.25% | 0.04 -64.90% | 0.11 N/A | |
Debt-to-Equity Ratio | 1.30 +68.67% | 0.77 +158.63% | -1.32 N/A | N/A N/A | |
Debt-to-Assets Ratio | 0.45 +50.12% | 0.30 -52.01% | 0.62 N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow